Mesothelioma
Studies & trials
- ASSESS-Meso*A multi-centre, prospective, longitudinal study aiming to improve knowledge about several aspects of mesothelioma. This study is not yet published."
- DIAPHRAGMA national, prospective, observational study investigating the role of biomarkers in the diagnosis of mesothelioma. This study is not yet published.
- MARS2A national randomised controlled trial comparing the outcomes of surgery for mesothelioma with non-surgical standard care. This study is not yet published.
- MesobanKA national biobank of mesothelioma tissue samples which aims to improve resources for future mesothelioma research. This study is not yet published.
- MESO-TrapA national randomised controlled trial comparing surgical decortication with indwelling pleural catheter for patients with mesothelioma and trapped lung. This study is not yet published.
- RESPECT-MesoA national randomised controlled trial comparing standard care with early specialist palliative care for patients with mesothelioma.
- SMART*A national randomised controlled trial comparing early radiotherapy to symptom-led radiotherapy following pleural intervention in mesothelioma.
- SWAMP*A longitudinal study examining the role of PET-CT and various biomarkers in the diagnosis and monitoring of mesothelioma.
- TILT*A feasibility randomised controlled trial of intrapleural immunotherapy for mesothelioma. This study is not yet published.
- Zol-A*A feasibility randomised controlled trial exploring the effect of zoledronic acid in patients with mesothelioma. This study is not yet published.
